Embleema co-founders Nicolas Schmidt, Chief Product Officer, CEO Robert Chu and Alexis Normand, Head of Embleema Blockchain Consortium
Embleema, which offers blockchain for health, announced Wednesday (February 6) that it has closed a $3.7 million Series A funding round, led by strategic partner Pharmagest, a leading pharmacy software group in Europe, and Techstars.
The funds will serve to accelerate the joint development of blockchain-based applications for patients and pharmacies, and further Embleema’s commercial deployment.
In July 2018, Embleema launched PatientTruth in the US, a blockchain-based personal health record system, which lets patients assemble their health history from dispersed health records and gives them full control over data sharing with smart contracts.
Patients receive tokens in exchange for their active participation in clinical research. Embleema claims it was the first company to offer practical means for patients to own their digital health assets, providing both control and monetization without third party data brokers. Now, it hopes to accelerate the release of the first decentralized marketplace for sharing Real World Evidence and Clinical Data.
Joining the 3-month Alchemist Blockchain Techstars Accelerator will enable Embleema to gain access to more than 150 mentors. The accelerator also provides investment capital to participating companies.
Techstars, a worldwide network that helps entrepreneurs, and Alchemist, a global blockchain advisory group, have partnered to bring a new mentorship-driven accelerator program to New York City: Alchemist Blockchain Techstars Accelerator.
Yossi Hasson of Techstars and Steven Nerayoff of Alchemist will lead the program along with other mentors and experts from both companies. The Accelerator will help Embleema founders gain access to expertise in the nascent – yet rapidly growing – cryptocurrency and blockchain industry.
Selected companies will not only benefit from resources across Techstars and Alchemist’s ecosystems, but will also have the opportunity to work closely with leading market players in the blockchain industry.